How to continue Topamax after moving to

If you’ve been struggling with binge eating disorder (BED), you’ve probably wondered whether you can get treatment without the hassle of in-person doctor visits. The short answer is yes—telehealth has opened new doors for accessing BED treatment, including medications that can help manage symptoms. But with ever-changing regulations and a patchwork of state laws, it’s natural to have questions about what’s legal, safe, and available.

In this comprehensive guide, we’ll walk you through everything you need to know about getting BED medication through telehealth in 2026, including which medications are available, how the process works, and what regulations govern online prescribing across different states.

Understanding Binge Eating Disorder and Treatment Options

Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of Americans. It’s characterized by recurring episodes of eating large quantities of food in a short period, accompanied by a feeling of loss of control and significant distress—without the compensatory purging behaviors seen in bulimia.

To meet DSM-5 diagnostic criteria for BED, you must experience binge eating episodes at least once per week for three months, along with marked distress about the behavior. These episodes typically involve eating much more rapidly than normal, eating until uncomfortably full, eating when not physically hungry, and feeling disgusted or guilty afterward.

While psychotherapy—particularly cognitive behavioral therapy (CBT)—remains the gold standard for BED treatment, medication can play an important supportive role, especially when combined with counseling and nutritional guidance.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Medications Commonly Prescribed for BED via Telehealth

Non-Controlled Medications: Your Telehealth Options

The good news for anyone seeking telehealth treatment is that the most commonly prescribed medications for BED are not controlled substances, which means they face far fewer regulatory restrictions when prescribed online.

Topiramate (Topamax) is an anticonvulsant medication originally approved for seizures and migraine prevention. While it’s used off-label for BED, research suggests it can help reduce binge frequency and support weight management. Healthcare providers typically start patients on a low dose and gradually increase it to minimize side effects like cognitive changes or tingling sensations.

Important consideration: Topiramate carries significant pregnancy risks, including increased chance of cleft palate and other birth defects. Women of childbearing age should use effective contraception while taking this medication.

Bupropion (Wellbutrin) is an antidepressant that’s also FDA-approved for smoking cessation. Studies have shown it may help reduce binge eating episodes in some patients. It works differently than typical antidepressants, affecting dopamine and norepinephrine rather than serotonin.

Critical warning: Bupropion is contraindicated in patients with a history of bulimia or anorexia nervosa due to increased seizure risk. It also carries a black box warning about increased suicidal thoughts in patients under 25, requiring close monitoring especially when starting treatment.

Why These Medications Work Well for Telehealth

Because topiramate and bupropion are non-controlled substances, they’re not subject to the strict federal Ryan Haight Act restrictions that govern online prescribing of controlled medications. This means:

• No mandatory in-person visit required under federal law
• Providers can prescribe them via video consultation in all 50 states (if licensed there)
• Refills can typically be authorized for 90 days or longer
• No required checks of state Prescription Drug Monitoring Programs (though providers may review your medication history as good practice)

This regulatory flexibility makes these medications ideal candidates for telehealth treatment, connecting patients with specialized care regardless of geographic location.

Federal Telehealth Prescribing Rules: What You Need to Know

The Current Regulatory Landscape (2026)

Understanding federal telehealth rules requires distinguishing between controlled and non-controlled medications—a distinction that dramatically affects your access to care.

For non-controlled medications (like topiramate and bupropion), there has never been a federal requirement for an in-person visit before prescribing via telehealth. The Ryan Haight Act of 2008, which restricts online prescribing, only applies to controlled substances (Schedule II-V medications like ADHD stimulants, opioids, and benzodiazepines).

For controlled substances, the rules are more complex and currently in flux. During the COVID-19 public health emergency, the DEA temporarily waived the Ryan Haight Act’s in-person examination requirement. This flexibility has been extended multiple times—most recently through December 31, 2026—while the DEA works on permanent regulations.

This means that throughout 2026, healthcare providers can continue prescribing both controlled and non-controlled medications via telehealth without a prior in-person visit, though permanent rules may change this landscape by 2027.

What Makes Telehealth Prescribing Legal and Safe

Legitimate telehealth providers must meet the same standards of care as in-person doctors. This includes:

• Establishing a valid patient-provider relationship through a comprehensive evaluation
• Conducting an appropriate medical examination (which can be done via video for most conditions)
• Documenting the medical need for any prescribed medication
• Obtaining informed consent for telehealth services
• Maintaining secure medical records in compliance with HIPAA

The key regulatory principle is that a telehealth exam must be equivalent in quality to an in-person evaluation, even if conducted differently. Many states have codified this explicitly in their telehealth laws.

State-by-State Variations: Does Your Location Matter?

While federal law sets the baseline, state regulations add another layer of requirements that can vary significantly depending on where you live. Here’s what you need to know about major state differences:

States with No In-Person Requirements

California has some of the most progressive telehealth laws in the nation. A 2025 update (AB 1503) explicitly confirmed that a ‘good faith examination’ can be conducted entirely through asynchronous telehealth (like secure messaging or questionnaires) for non-controlled medications, as long as it meets the appropriate standard of care.

New York similarly has no in-person requirement for non-controlled medications. However, New York did implement new rules in May 2025 requiring an in-person visit before prescribing most controlled substances via telehealth (with limited exceptions)—but this doesn’t affect BED medications like topiramate or bupropion.

Texas, Delaware, Michigan, Wisconsin, and South Carolina all allow telehealth prescribing of non-controlled medications without any mandatory in-person visit, as long as standard care protocols are followed.

States Requiring Periodic In-Person Follow-Up

A handful of states require patients receiving ongoing telehealth care to be seen in person periodically:

Alabama requires that if a patient has more than four telehealth visits for the same condition within 12 months, they must be seen in person within that year. However, this requirement can be satisfied by seeing any healthcare provider at the practice location (not necessarily the telehealth prescriber).

Georgia mandates that providers ‘attempt’ an in-person examination at least annually for ongoing telemedicine patients. The initial evaluation can be done via telehealth if it’s clinically equivalent to an in-person exam.

New Hampshire recently updated its laws (effective August 2025) to allow even controlled substances to be prescribed via telehealth initially, but requires an in-person follow-up exam within 12 months for continued treatment.

These periodic requirements generally don’t prevent you from starting treatment via telehealth—they just mean you’ll need to plan for an eventual in-person visit if care continues long-term.

Can Nurse Practitioners Prescribe BED Medications?

The answer depends on your state’s scope of practice laws for advanced practice registered nurses (APRNs).

Full Practice Authority States (34 states plus DC as of 2026): In these states, nurse practitioners can evaluate, diagnose, and prescribe medications independently without physician oversight. This includes all the medications discussed in this article. Recent additions to this list include Wisconsin and Michigan (both passed full practice authority laws in 2025), joining states like California, New York, New Hampshire, and Delaware.

Collaborative Practice States: In states like Texas, Florida, Georgia, and Alabama, NPs can prescribe these medications but must work under a collaborative agreement with a physician. This is handled behind the scenes and typically doesn’t affect your care experience—you may just see both names on documentation.

The good news: in every state, nurse practitioners can prescribe topiramate and bupropion for BED when working within their state’s scope of practice rules. The same applies to physician assistants, who can prescribe under supervision in all 50 states.

For patients, this means expanded access to care through Klarity Health and similar platforms that employ diverse provider teams, including both physicians and advanced practice providers who can meet you where you are.

The Telehealth Treatment Process: What to Expect

Your Initial Evaluation

A legitimate telehealth evaluation for BED should be thorough—typically lasting 30-45 minutes or more for your first appointment. Your provider will:

• Ask detailed questions about your eating patterns, including frequency and characteristics of binge episodes
• Review your mental health history, including any depression, anxiety, or trauma
• Discuss previous treatments you’ve tried, including therapy or diet programs
• Screen for other eating disorders and medical conditions
• Review your complete medication list and any substance use
• Assess whether you’re a good candidate for medication treatment

Don’t be surprised if your provider asks you to complete standardized questionnaires like the Binge Eating Scale (BES) or asks you to keep a food/mood diary. These tools help establish a baseline and track your progress.

Safety Screening and Contraindications

Your telehealth provider must screen for conditions that would make certain BED medications unsafe:

For bupropion (Wellbutrin), automatic exclusions include:

• Current or past diagnosis of bulimia or anorexia nervosa (high seizure risk)
• Active seizure disorder or history of seizures
• Abrupt discontinuation of alcohol or benzodiazepines (increases seizure risk)
• Use of MAO inhibitors within the past 14 days

For topiramate (Topamax), special considerations include:

• Pregnancy or inadequate contraception (teratogenic risk)
• History of kidney stones
• Glaucoma
• Metabolic acidosis

If you have any of these conditions, a responsible telehealth provider will either recommend a different medication or refer you for in-person evaluation. This isn’t a limitation of telehealth—it’s simply good medicine.

How Prescriptions Work

Once your provider determines that medication is appropriate, they’ll electronically send your prescription to a pharmacy of your choice. You should:

• Pick up medications from a licensed pharmacy (in-person or through legitimate mail-order services like major retail pharmacy mail programs)
• Avoid providers who ship medications directly without using a pharmacy—this is a red flag
• Expect to start at a low dose, especially with topiramate, which requires gradual titration
• Receive clear instructions on dosing, potential side effects, and what to watch for

For non-controlled medications like these, prescribers can typically authorize refills for 6-12 months, though you’ll still need regular follow-up visits to monitor your response and safety.

Follow-Up Care and Monitoring

Quality telehealth care includes regular check-ins, typically:

• 2-4 weeks after starting medication to assess initial tolerance and side effects
• Monthly visits during dose adjustment periods
• Every 2-3 months once stable on an effective dose
• As-needed contact for concerns or side effects

During follow-ups, your provider should assess:

• Changes in binge eating frequency and severity
• Mood changes (particularly with bupropion)
• Side effects like cognitive changes, weight changes, or other medication effects
• Whether you’re also engaging in therapy or other supportive treatments
• Any need for dose adjustments

Klarity Health’s model of accessible, ongoing care means you’re not just getting a prescription—you’re building a relationship with a provider who tracks your progress over time, adjusts treatment as needed, and coordinates with other aspects of your care.

Understanding Off-Label Use and FDA Status

Neither topiramate nor bupropion is FDA-approved specifically for BED treatment. The only FDA-approved medication for BED is lisdexamfetamine (Vyvanse), a controlled stimulant—which brings us to an important point about off-label prescribing.

Why Off-Label Prescribing Is Common and Legal

Off-label prescribing means using a medication for a condition other than what the FDA originally approved it for. This practice is:

• Completely legal and extremely common (an estimated 20% of all prescriptions are off-label)
• Often supported by research even without formal FDA approval for that specific use
• Considered standard of care for many conditions, including BED

For BED specifically, clinical studies support both topiramate and bupropion as potential treatment options. Research has shown that topiramate can reduce binge frequency and body weight in BED patients, while bupropion may help with the impulsivity and mood components that often accompany the disorder.

Your telehealth provider should:

• Explain that the medication is being used off-label
• Discuss the evidence supporting its use for BED
• Review alternative options including FDA-approved medications (even if they’re harder to access via telehealth)
• Obtain your informed consent for off-label use

This transparency is part of good medical practice and helps you make informed decisions about your treatment.

Why Not Prescribe Vyvanse via Telehealth?

Vyvanse (lisdexamfetamine) is FDA-approved for BED, so why don’t most telehealth providers offer it?

The answer comes down to its Schedule II controlled substance status. While the DEA’s temporary flexibility allows controlled substance prescribing via telehealth through the end of 2026, many legitimate telehealth platforms have chosen not to prescribe stimulants remotely due to:

• Abuse potential and diversion risks associated with stimulant medications
• Uncertain permanent regulations—providers are cautious about building care models around temporary rules
• State-specific restrictions—some states have already implemented stricter rules for controlled substance telehealth
• Reputational and compliance concerns following high-profile enforcement actions against telehealth companies that inappropriately prescribed stimulants

This conservative approach protects both patients and providers, focusing telehealth on medications that can be safely and legally prescribed long-term without regulatory uncertainty.

Red Flags: Identifying Unsafe Telehealth Practices

The expansion of telehealth has brought tremendous benefits, but also created opportunities for bad actors. Here’s how to identify and avoid unsafe online prescribing:

Warning Signs of Problematic Telehealth Services

Be cautious if a platform:

• Promises a prescription before any evaluation
• Offers a ‘diagnosis’ based only on a brief questionnaire with no live provider interaction
• Doesn’t require video consultation (at minimum) before prescribing
• Ships medications directly without using a licensed pharmacy
• Doesn’t clearly identify the prescribing provider by name and credentials
• Provides no way to follow up or ask questions after the initial visit
• Doesn’t screen for contraindications or ask about medical history

Major red flags include:

• Prescribing without verifying your identity and location
• Offering controlled substances with minimal evaluation (like the now-defunct ADHD telehealth company whose executives faced criminal charges for unsafe stimulant prescribing practices)
• Charging large upfront fees with no clear explanation of what’s included
• Pressure to purchase supplements or additional products

What Legitimate Telehealth Should Look Like

High-quality services like Klarity Health demonstrate their commitment to safety through:

Comprehensive evaluations: Initial visits lasting 30+ minutes with licensed providers who ask detailed questions about symptoms, history, and lifestyle

Transparent pricing: Clear information about consultation fees, medication costs, and insurance coverage (Klarity accepts both insurance and self-pay)

Licensed providers in your state: Verification that the person treating you is licensed to practice medicine in your location

Proper documentation: Medical records, treatment plans, and informed consent processes that mirror in-person care

Follow-up care: Regular monitoring appointments and accessible communication between visits

Integrated approach: Recognition that medication is one tool among many, often combined with therapy referrals and lifestyle interventions

Insurance Coverage and Cost Considerations

Does Insurance Cover Telehealth for BED?

Most health insurance plans now cover telehealth visits at the same rate as in-person appointments—a change that became permanent after COVID-19 demonstrated telehealth’s value. However, coverage specifics vary:

For the medical visit:

• Medicare covers telehealth for mental health services, though exact coverage for eating disorder treatment varies
• Most private insurance plans cover telehealth consultations, often with the same copay as office visits
• Medicaid coverage varies by state but generally includes telehealth mental health services

For medications:

• Topiramate and bupropion are both generic and typically covered by insurance
• Copays are usually low for generics (often $10-30 per month)
• Prior authorization is rarely required for these medications when prescribed for labeled uses, though off-label use for BED might occasionally trigger a review

Klarity Health accepts both insurance and self-pay, providing flexibility if you prefer to pay out-of-pocket for privacy reasons or if your insurance has high deductibles.

Cash-Pay Options

For those paying out-of-pocket, costs are generally reasonable:

• Initial evaluation: Typically $150-300
• Follow-up visits: Usually $75-150
• Medications: Generic topiramate and bupropion cost $10-50/month without insurance at most pharmacies

Klarity Health’s transparent pricing model means you know costs upfront, without surprise bills or hidden fees.

Comparing Telehealth to In-Person BED Treatment

Integrating Telehealth Medication with Comprehensive BED Treatment

While medication can be helpful, the most effective BED treatment typically includes multiple components:

The Role of Psychotherapy

Cognitive Behavioral Therapy (CBT) specifically adapted for eating disorders is considered the gold standard treatment for BED. CBT helps you:

• Identify triggers for binge eating episodes
• Develop healthier coping strategies
• Challenge distorted thoughts about food, weight, and body image
• Establish regular eating patterns
• Build skills to prevent relapse

Many patients find that combining medication with therapy produces better results than either approach alone. Medication may help reduce the urgency of binge impulses, while therapy addresses the underlying patterns and triggers.

Klarity Health can connect you with mental health professionals for therapy in addition to medication management, creating a coordinated treatment approach.

Nutritional Counseling

Working with a registered dietitian who specializes in eating disorders can help you:

• Develop a balanced, non-restrictive eating plan
• Understand hunger and fullness cues
• Navigate challenging food situations
• Address nutritional deficiencies
• Break the restrict-binge cycle

Support Systems

Recovery from BED often benefits from:

• Support groups (in-person or online through organizations like NEDA or Overeaters Anonymous)
• Family education and involvement
• Addressing co-occurring conditions like depression, anxiety, or trauma
• Stress management and self-care practices

The most successful outcomes typically come from addressing BED as a complex condition requiring multifaceted treatment, not just a medication prescription.

Special Populations and Considerations

Pregnancy and Breastfeeding

Topiramate is contraindicated during pregnancy due to well-documented teratogenic effects, including increased risk of cleft lip/palate and other birth defects. If you’re pregnant, planning to become pregnant, or not using reliable contraception, topiramate is not appropriate.

Bupropion during pregnancy is generally considered safer than topiramate but still requires careful risk-benefit analysis. It’s classified as pregnancy category C, meaning risk cannot be ruled out.

If you’re breastfeeding, both medications pass into breast milk in varying amounts. Your provider will need to weigh the benefits of medication against potential infant exposure.

For pregnant or breastfeeding individuals, therapy-focused treatment is typically the safer first-line approach for BED.

Adolescents and Young Adults

BED can begin in adolescence, but medication treatment in this population requires special consideration:

• Bupropion carries a black box warning about increased suicidal thoughts in people under 25, requiring very close monitoring
• Developmental factors may make therapy more appropriate as first-line treatment
• Family involvement is typically more important in adolescent eating disorder treatment

Any adolescent receiving medication for BED should have frequent follow-up and ideally concurrent therapy.

Patients with Co-occurring Conditions

Many people with BED also experience:

• Depression or anxiety: May benefit from bupropion’s antidepressant effects
• ADHD: May have overlapping impulsivity issues; however, stimulant medications for ADHD could complicate BED (and generally aren’t prescribed via telehealth)
• Obesity-related health conditions: Weight changes from BED medications may help, but shouldn’t be the primary focus of treatment
• Substance use concerns: Bupropion shouldn’t be used during active alcohol withdrawal; careful assessment needed

Your telehealth provider should take a comprehensive approach, considering how BED interacts with other aspects of your health.

Looking Ahead: The Future of Telehealth for Eating Disorders

The regulatory landscape continues to evolve. Here’s what to watch:

Pending Federal Regulations

The DEA has indicated it will finalize permanent rules for telehealth controlled substance prescribing by the end of 2026. These rules may:

• Require special registration for telehealth prescribers
• Implement specific security and identity verification standards
• Potentially require an in-person visit before or during controlled substance treatment

For BED patients, these changes are unlikely to affect access to topiramate or bupropion, but could impact Vyvanse access if that becomes available via telehealth.

State-Level Changes

Several states are considering legislation to:

• Expand nurse practitioner practice authority (making specialized care more accessible)
• Standardize telehealth coverage and reimbursement
• Create clearer guidelines for telehealth prescribing standards

Alabama and South Carolina have ongoing discussions about NP independence that could expand provider availability in those states.

Technology Advances

Emerging technologies may enhance telehealth BED treatment:

• Remote monitoring tools that track eating patterns and mood
• AI-assisted screening to identify patients who might benefit from medication
• Integrated platforms connecting medication management, therapy, and peer support
• Improved asynchronous care options for follow-up between visits

Making the Decision: Is Telehealth BED Treatment Right for You?

Telehealth medication treatment for BED is an excellent option if you:

✅ Have limited access to eating disorder specialists in your area
✅ Prefer the convenience and privacy of remote care
✅ Are comfortable with technology and have reliable internet access
✅ Don’t have contraindications to topiramate or bupropion
✅ Are willing to engage in regular follow-up appointments
✅ Ideally, are also receiving or willing to receive therapy

Consider supplementing with in-person care if you:

⚠️ Have complex medical conditions requiring hands-on examination
⚠️ Are pregnant, breastfeeding, or planning pregnancy
⚠️ Have a history of seizures or other conditions that complicate medication choice
⚠️ Prefer or require the FDA-approved medication Vyvanse
⚠️ Need intensive eating disorder treatment or have severe medical complications from BED
⚠️ Have co-occurring substance use disorders

How to Get Started with Klarity Health

If you’re ready to explore telehealth treatment for Binge Eating Disorder, Klarity Health offers:

Provider Availability: Connect with licensed mental health providers in your state, often with appointments available within 24-48 hours—much faster than typical specialty care wait times.

Transparent Pricing: Know exactly what you’ll pay upfront, whether using insurance or self-pay options. No hidden fees or surprise bills.

Flexible Payment Options: Klarity accepts both insurance and cash pay, giving you choice in how you manage your healthcare costs.

Comprehensive Approach: Access to both medication management and therapy services, creating integrated care for the best outcomes.

Quality Care Standards: All providers are fully licensed in your state and follow evidence-based treatment protocols, with thorough evaluations and regular follow-up.

The process is straightforward: complete an online assessment, schedule a video visit with a provider, discuss your symptoms and treatment options, and if appropriate, receive a prescription sent directly to your pharmacy. Throughout your treatment, you’ll have ongoing access to your provider for adjustments and support.

Conclusion

Telehealth has transformed access to Binge Eating Disorder treatment, making evidence-based care available to people who might otherwise struggle to find specialized help. Medications like topiramate and bupropion can be safely and legally prescribed via telehealth in all 50 states, with minimal regulatory barriers for non-controlled substances.

The key is choosing a reputable provider who conducts thorough evaluations, provides ongoing monitoring, and treats medication as one component of comprehensive BED care. While not appropriate for everyone, telehealth offers a convenient, private, and effective pathway to treatment for many people struggling with this common but often under-treated eating disorder.

If binge eating is impacting your quality of life, you don’t have to face it alone—and you don’t necessarily have to face it in person. Quality help is just a video call away.

Research Currency Statement

Verified as of: January 4, 2026

• DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

• States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

• Sources Newer Than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

• Flagged for Follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Top 5 Citations

1. HHS Press Release (January 2026): DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026 – www.hhs.gov

2. Sheppard Mullin Health Law Blog (August 2025): Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions – www.sheppardhealthlaw.com

3. Center for Connected Health Policy (2025): State Telehealth Laws and Reimbursement Policies – Online Prescribing Database – www.cchpca.org

4. Health Jobs Nationwide Blog (2025): State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025) – blog.healthjobsnationwide.com

5. National Law Review (2025): Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions – natlawreview.com

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12